Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Total Revenue of $296.15 million for fiscal year 2025.
IRONWOOD PHARMACEUTICALS INC Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $296.15M | -15.7% |
| 2024 | $351.41M | -20.6% |
| 2023 | $442.74M | +7.8% |
| 2022 | $410.60M | -0.8% |
| 2021 | $413.75M | +6.2% |
| 2020 | $389.52M | -9.1% |
| 2019 | $428.41M | +23.6% |
| 2018 | $346.64M | +16.2% |
| 2017 | $298.28M | +8.9% |
| 2016 | $273.96M | +83.2% |
| 2015 | $149.56M | +95.7% |
| 2014 | $76.44M | +234.1% |
| 2013 | $22.88M | -84.8% |
| 2012 | $150.25M | +128.1% |
| 2011 | $65.87M | +50.2% |
| 2010 | $43.86M | +27.8% |
| 2009 | $34.32M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $122.06M | +33.3% | +43.2% |
| June 30, 2025 | $85.24M | -9.7% | +107.2% |
| March 31, 2025 | $41.14M | -45.1% | -55.1% |
| September 30, 2024 | $91.59M | -19.5% | -3.0% |
| June 30, 2024 | $94.40M | -12.1% | +26.1% |
| March 31, 2024 | $74.88M | -28.0% | -34.2% |
| September 30, 2023 | $113.74M | +4.7% | +5.9% |
| June 30, 2023 | $107.38M | +10.4% | +3.2% |
- IRONWOOD PHARMACEUTICALS INC showed a decrease of -15.7% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, IRONWOOD PHARMACEUTICALS INC’s total revenue has grown by 762.9% (from $34.32 million to $296.15 million).
- The most recent figure is from IRONWOOD PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: